HOME >> BIOLOGY >> NEWS
The World Economic Forum announces new class of technology pioneers for 2006: Ossur selected

a critical role in driving the company towards reaching its goals.
  • Status. The company must not currently be a Member of the World Economic Forum. This criterion applies to the parent company thus wholly-owned subsidiaries of large firms are not eligible.
  • Nominees are evaluated by an external review committee comprised of technology experts with respect to the criteria above.

    In 2005, Ossur single-handedly transformed the nature of prosthetics with the launch of Bionic Technology by Ossur, a new technology platform which pushes the boundary of existing functional capabilities. Founded upon an interdiciplinary and precise fusion of electronics, mechanics, and human physiology, this new range of products includes Ossur's new products: the RHEO KNEETM and the POWER KNEETM, and will soon address the orthopedic market, as well. The goals are to remove the physical limitations caused by a patient's disability; remove the morbidity inherent in some conventional designs; and make the technology available to a wider group of patients.

    The uniqueness of the Technology Pioneer network ensures that companies involved in the development of new technologies are engaged in an integrated and interdisciplinary way. The Technology Pioneers community will provide the Foundation and its members with in-depth knowledge of some of the key technology issues facing society.


    '"/>

    Contact: Beverly Millson
    beverly@missingsock.com
    310-399-7599
    Ossur
    4-Dec-2005


    Page: 1 2 3

    Related biology news :

    1. World Wildlife Fund warns against iron dumping experiment near the Galapagos Islands
    2. Worlds first X-ray free electron laser is on course to completion
    3. Worlds leading scientists announce creation of Encyclopedia of Life
    4. Prize winners announced at ISNs World Congress of Nephrology
    5. World first test potential to identify breast cancer patients who will react badly to radiotherapy
    6. Worlds top engineers in San Antonio for system of systems conference
    7. OneWorld Health selects Odyssey Research for phase 4 study in India
    8. MicrobeWorld podcast wins another award
    9. International Astronautical Federation joins project to protect World Heritage sites
    10. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
    11. Nature Genetics and the International Society of Nephrology come to Danvers on World Kidney Day

    Post Your Comments:
    (Date:4/27/2015)... ATLANTA , April 27, 2015  For more ... and trade show has been the premier worldwide event ... Systems 2015 is a must-attend event for any local, ... insight into the emerging commercial markets and current applications ... and innovations of this projected $48 billion industry, and ...
    (Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
    (Date:4/14/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® smart ... Design Awards under the category  ,Product Design – Technology,. ... are part of a global multi-disciplinary awards program. The ... marketplace, industry and judging panel. Winners will be announced ...
    Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
    (Date:5/21/2015)... Calif. , May 21, 2015  The ... Orrin Hatch (R-UT) and Amy Klobuchar ... Extensions Now Accelerating Cures & Treatments, or OPEN ... rare disease patient advocacy organizations, this bipartisan legislation ... and affordable medicines to rare disease patients by ...
    (Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
    (Date:5/21/2015)... Kingston, Ontario (PRWEB) May 21, 2015 ... entered into an exclusive North American distribution agreement ... microbiology testing system. , With more than 160 ... of products and services for laboratory and production ... choice, operational excellence and differentiated services to enable ...
    (Date:5/20/2015)... 2015 This year has been one ... US Patented Pearl’s Premium Ultra Low Maintenance Lawn ... country that are coming out of record bad weather. ... of major global concerns related to water, health, and ... the alternative to the standard, water-wasting, chemical-treated standard lawn. ...
    Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
    Cached News: